Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Drewry

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|May 28, 2020
HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular ToxicityAlison Howarth, Martin Schröder, Raquel C Montenegro, et al.
Biomaterials Science|September 4, 2025
A soft-stiff patterned bioengineering model reveals kinase pathways driving directional cell migration in pulmonary arterial hypertensionTamanna Islam, Jacob Hooper, Xiaojun Zhang, et al.
ACS Infectious Diseases|July 31, 2018
GW779439X and Its Pyrazolopyridazine Derivatives Inhibit the Serine/Threonine Kinase Stk1 and Act As Antibiotic Adjuvants against β-Lactam-Resistant Staphylococcus aureusAdam J Schaenzer, Nathan Wlodarchak, David H Drewry, et al.
Journal of Medicinal Chemistry|August 2, 2021
Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving NeurodegenerationDavid H Drewry, Joel K Annor-Gyamfi, Carrow I Wells, et al.
Frontiers in Molecular Biosciences|March 25, 2024
Illumination of understudied ciliary kinasesRaymond G Flax, Peter Rosston, Cecilia Rocha, et al.
Journal of Medicinal Chemistry|February 6, 2026
Cellular Context Influences Kinase Inhibitor SelectivityMatthew J Binder, Frances M Bashore, Kaitlin K Dunn Hoffman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Cellular Selectivity Analyses Reveal Distinguishing Profiles for Type II Kinase InhibitorsMatthew J Binder, Frances M Bashore, Kaitlin K Dunn Hoffman, et al.
Cancers|April 13, 2023
NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer TypesKhoa Nguyen, Julia Boehling, Minh N Tran, et al.
Journal of Medicinal Chemistry|September 20, 2021
Design and Development of a Chemical Probe for Pseudokinase Ca<sup>2+</sup>/calmodulin-Dependent Ser/Thr KinaseNadine Russ, Martin Schröder, Benedict-Tilman Berger, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Characterization of 2,4-Dianilinopyrimidines Against Five <i>P. falciparum</i> Kinases PfARK1, PfARK3, PfNEK3, PfPK9, and PfPKBHan Wee Ong, Chandi de Silva, Krisha Avalani, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
SLAS Discovery : Advancing Life Sciences R & D|May 28, 2020
HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular ToxicityAlison Howarth, Martin Schröder, Raquel C Montenegro, et al.
Biomaterials Science|September 4, 2025
A soft-stiff patterned bioengineering model reveals kinase pathways driving directional cell migration in pulmonary arterial hypertensionTamanna Islam, Jacob Hooper, Xiaojun Zhang, et al.
ACS Infectious Diseases|July 31, 2018
GW779439X and Its Pyrazolopyridazine Derivatives Inhibit the Serine/Threonine Kinase Stk1 and Act As Antibiotic Adjuvants against β-Lactam-Resistant Staphylococcus aureusAdam J Schaenzer, Nathan Wlodarchak, David H Drewry, et al.
Journal of Medicinal Chemistry|August 2, 2021
Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving NeurodegenerationDavid H Drewry, Joel K Annor-Gyamfi, Carrow I Wells, et al.
Frontiers in Molecular Biosciences|March 25, 2024
Illumination of understudied ciliary kinasesRaymond G Flax, Peter Rosston, Cecilia Rocha, et al.
Journal of Medicinal Chemistry|February 6, 2026
Cellular Context Influences Kinase Inhibitor SelectivityMatthew J Binder, Frances M Bashore, Kaitlin K Dunn Hoffman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Cellular Selectivity Analyses Reveal Distinguishing Profiles for Type II Kinase InhibitorsMatthew J Binder, Frances M Bashore, Kaitlin K Dunn Hoffman, et al.
Cancers|April 13, 2023
NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer TypesKhoa Nguyen, Julia Boehling, Minh N Tran, et al.
Journal of Medicinal Chemistry|September 20, 2021
Design and Development of a Chemical Probe for Pseudokinase Ca<sup>2+</sup>/calmodulin-Dependent Ser/Thr KinaseNadine Russ, Martin Schröder, Benedict-Tilman Berger, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Characterization of 2,4-Dianilinopyrimidines Against Five <i>P. falciparum</i> Kinases PfARK1, PfARK3, PfNEK3, PfPK9, and PfPKBHan Wee Ong, Chandi de Silva, Krisha Avalani, et al.
Pageof 12